Eterobarb

Summary

Eterobarb (Antilon) is a barbiturate derivative. It has mainly anticonvulsant action with less sedative effects than the closely related compound phenobarbital. It saw reasonable success in clinical trials, but is not in widespread medical use.[1][2]

Eterobarb
Clinical data
Routes of
administration
Oral
ATC code
  • none
Identifiers
  • 5-ethyl-1,3-bis(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione
CAS Number
  • 27511-99-5 checkY
PubChem CID
  • 33925
ChemSpider
  • 31271 ☒N
UNII
  • 432SI047GA
KEGG
  • D04077 checkY
CompTox Dashboard (EPA)
  • DTXSID9045710 Edit this at Wikidata
Chemical and physical data
FormulaC16H20N2O5
Molar mass320.345 g·mol−1
3D model (JSmol)
  • Interactive image
  • CCC1(C(=O)N(C(=O)N(C1=O)COC)COC)C2=CC=CC=C2
  • InChI=1S/C16H20N2O5/c1-4-16(12-8-6-5-7-9-12)13(19)17(10-22-2)15(21)18(11-23-3)14(16)20/h5-9H,4,10-11H2,1-3H3 ☒N
  • Key:DACOQFZGGLCXMA-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Synthesis edit

Eterobarb can be synthesized by reacting phenobarbital with chloromethyl methyl ether in presence of a base.[3]

 
Eterobarb synthesis

References edit

  1. ^ Gallagher BB, Baumel IP, Woodbury SG, Dimicco JA (May 1975). "Clinical evaluation of eterobarb, a new anticonvulsant drug". Neurology. 25 (5): 399–404. doi:10.1212/wnl.25.5.399. PMID 1094318. S2CID 35510833.
  2. ^ Smith DB, Goldstein SG, Roomet A (1986). "A comparison of the toxicity effects of the anticonvulsant eterobarb (antilon, DMMP) and phenobarbital in normal human volunteers". Epilepsia. 27 (2): 149–55. doi:10.1111/j.1528-1157.1986.tb03518.x. PMID 3956454. S2CID 20206800.
  3. ^ Vida JA, Wilber WR, Reinhard JF (March 1971). "Anticonvulsants. 2. Acyloxymethyl and halomethyl derivatives of barbituric acid and diphenylhydantoin". Journal of Medicinal Chemistry. 14 (3): 187–9. doi:10.1021/jm00285a002. PMID 5552206.